Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Baraclude launched in U.K.

Sep. 5, 2006

ITMN-191 continues preclinical development, clinical trials warranted

Aug. 30, 2006

Resistance to peginterferon/ribavirin conferred by increased expression of interferon genes

Aug. 30, 2006

Colazal receives pediatric exclusivity

Aug. 30, 2006

Recent patents report novel therapeutic agents for hepatitis C virus infection

Aug. 30, 2006

ChronVac-C with Medpulser DDS shows good immune response in rabbits

Aug. 29, 2006

Probactrix studied for dietary management of GERD

Aug. 29, 2006

GSK and ChemoCentryx establish strategic alliance in inflammatory disorders

Aug. 28, 2006

Once-daily dosing of oral methylnaltrexone studied in phase II trial

Aug. 24, 2006

Safety and activity of fontolizumab evaluted in Crohn's disease patients

Aug. 21, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...